Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
CanadaIPO:
13 March 2015Website:
http://www.essapharma.comNext earnings report:
08 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 21 Jun 2024 20:04:23 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is ESSA Pharma?
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
What sector is ESSA Pharma in?
ESSA Pharma is in the Healthcare sector
What industry is ESSA Pharma in?
ESSA Pharma is in the Biotechnology industry
What country is ESSA Pharma from?
ESSA Pharma is headquartered in Canada
When did ESSA Pharma go public?
ESSA Pharma initial public offering (IPO) was on 13 March 2015
What is ESSA Pharma website?
https://www.essapharma.com
Is ESSA Pharma in the S&P 500?
No, ESSA Pharma is not included in the S&P 500 index
Is ESSA Pharma in the NASDAQ 100?
No, ESSA Pharma is not included in the NASDAQ 100 index
Is ESSA Pharma in the Dow Jones?
No, ESSA Pharma is not included in the Dow Jones index
When does ESSA Pharma report earnings?
The next expected earnings date for ESSA Pharma is 08 August 2024